As of January this year, California, New Hampshire, Pennsylvania and South Carolina ended Medicaid GLP-1 drug coverage for weight loss, and Michigan started restricting coverage to people classified as morbidly obese, meaning they have a body mass index above 40
R., Malatestinic, W
10.1158/1535-7163.MCT-08-0250 Mol
Lab handling should follow established protocols for research compounds, including personal protective equipment and contamination prevention measures
Quick Answer: GLP-1 medications suppress thirst signals and increase the rate at which your kidneys excrete sodium
This is evidenced by inconsistent recruitment of PINK1/Parkin to the mitochondria, overaccumulation of LC3-I and/or LC3-II, and insufficient fusion of mitochondria with lysosomes (Vaillant-Beuchot et al., 2021)